PepGen Inc. Share Price & Technical Analysis
PEPG · $1.51 (-1.95%)
Healthcare / Biotechnology
$1.51
-1.95%
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatme…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-6% return in May, 7% avg return in past 3 year May month.
-85% return in 2026, 94% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -22% | 24% | -70% | -11% | -6% | – | – | – | – | – | – | – | -85% |
| 25 | -66% | 129% | -55% | 14% | -6% | -27% | 27% | -8% | 283% | -8% | 39% | 3% | 327% |
| 24 | 47% | 70% | -14% | -16% | 28% | -1% | -28% | -14% | -10% | -23% | -23% | -24% | -8% |
| 23 | 15% | -2% | -20% | 21% | -1% | -38% | -32% | 5% | -20% | 0% | -4% | 39% | -37% |
| 22 | – | – | – | – | -28% | -12% | 14% | -14% | -4% | 35% | 19% | -11% | 0% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$113.78M
P/E ratio
—
52W high
$7.80
52W low
$1.01
Volume
5,66,698
Beta
2.01
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is PepGen Inc. share price today?
- PepGen Inc. (PEPG) last traded around $1.51 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PEPG have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PEPG. Download the app for real-time alerts.
- How can I analyze PepGen Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.